1887

Chapter 35 : Nontuberculous Mycobacteria—Introduction

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $15.00

Preview this chapter:
Zoom in
Zoomout

Nontuberculous Mycobacteria—Introduction, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555817138/9781555815134_Chap35-1.gif /docserver/preview/fulltext/10.1128/9781555817138/9781555815134_Chap35-2.gif

Abstract:

Nucleic acid probes are available for the most frequently seen mycobacterial species, complex, complex, , and . It has seemed as if there is an increase in nontuberculous mycobacteria (NTM) disease in the United States and other developed countries in recent years, but it has not been clear whether this is a true increase or just better detection. Early on, pulmonary NTM infections seemed to occur mainly in persons who had previous structural lung disease, such as chronic obstructive pulmonary disease, tuberculosis, histoplasmosis, or other causes of bronchiectasis. A more recent cause of immune-suppressiontriggered NTM lung diseases (and NTM disease generally) has been the introduction of biologic agents, especially tumor necrosis factor alpha inhibitor. The 2007 ATS/IDSA Statement includes a section in which the authors conclude that "more fundamental information is needed to improve understanding in essentially all areas of NTM disease". A combination of clinical, radiologic, and bacteriologic features has been suggested for diagnosis of true pulmonary NTM disease. Evaluation should include, beside appropriate history and physical, chest imaging using high-resolution computed tomography (HRCT), unless there is obvious cavitation by chest X ray. If possible, NTM should be identified at the species level. Patients suspected of having NTM disease should be monitored closely until the diagnosis is made or excluded.

Citation: Yeager H. 2011. Nontuberculous Mycobacteria—Introduction, p 525-530. In Schlossberg D (ed), Tuberculosis and Nontuberculous Mycobacterial Infections, Sixth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817138.ch35

Key Concept Ranking

Tumor Necrosis Factor alpha
0.481857
0.481857
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of Figure 1.
Figure 1.

Classification according to Timpe and Runyon. Reprinted from , 5th ed., edited by D. Schlossberg, with permission of McGraw-Hill, New York, NY.

Citation: Yeager H. 2011. Nontuberculous Mycobacteria—Introduction, p 525-530. In Schlossberg D (ed), Tuberculosis and Nontuberculous Mycobacterial Infections, Sixth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817138.ch35
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555817138.ch35
1. Alvarez-Uria, G. 2010. Lung disease caused by nontuberculous mycobacteria. Curr. Opin. Pulm. Med. 16:251256.
2. Billinger, M. E.,, K. N. Olivier,, C. Viboud,, R. M. de Oca,, C. Steiner,, S. M. Holland, and, D. R. Prevots. 2009. Hospitalizations for nontuberculous mycobacteria-associated lung disease, United States, 1998-2005. Emerg. Infect. Dis. 15:15621569.
3. Cassidy, P. M.,, K. Hedberg,, A. Saulson,, E. McNelly, and, K. L. Winthrop. 2009. Nontuberculous mycobacterial disease prevalence and risk factors: a changing epidemiology. Clin. Infect. Dis. 49:e124e129.
4. Chapman, J. S. 1977. The Atypical Mycobacteria and Human Mycobacterioses. Plenum Publishing Co., New York, NY.
5. Falkinham, J. O., III. 2009. The biology of environmental mycobacteria. Environ. Microbiol. Rep. 1:477487.
6. Feazel, L. M.,, L. K. Baumgartner,, K. L. Peterson,, D. N. Frank,, J. K. Harris, and, N. R. Pace. 2009. Opportunistic pathogens enriched in showerhead biofilms. Proc. Natl. Acad. Sci. USA 106:1639316399.
7. Griffith, D. E.,, T. Aksamit,, B. A. Brown-Elliott,, A. Catanzaro,, C. Daley,, F. Gordin,, S. M. Holland,, R. Horsburgh,, G. Huitt,, M. F. Iademarco,, M. Iseman,, K. Olivier,, S. Ruoss,, C. F. Von Reyn,, R. J. Wallace, Jr., and, K. Winthrop, on behalf of the ATS Mycobacterial Diseases Subcommittee. 2007. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am. J. Respir. Crit. Care Med. 175:367416.
8. Griffith, D. E. 2010. Nontuberculous mycobacterial disease. Curr. Opin. Infect. Dis. 23:185190.
9. Hall, L.,, K. A. Doerr,, S. L. Wohlfiel, and, G. D. Roberts. 2003. Evaluation of the MicroSeq system for identification of mycobacteria by 16S ribosomal DNA sequencing and its integration into a routine clinical mycobacteriology laboratory. J. Clin. Microbiol. 41:14471453.
10. Iseman, M. D.,, and T. K. Marras. 2008. The importance of nontuberculous mycobacterial disease. Am. J. Respir. Crit. Care Med. 178:9991000.
11. Khan K., K. J. Wang,, and T. K. Marras. 2010. Nontuberculous mycobacterial sensitization in the United States. Am. J. Respir. Crit. Care Med. 176:306311.
12. Kim, R. D.,, D. E. Greenberg,, M. E. Ehrmantraut,, S. V. Guide,, L. Ding,, Y. Shea,, M. R. Brown,, M. Chernick,, W. K. Steagall,, C. G. Glasgow,, J. Lin,, C. Jolley,, L. Sorbara,, M. Raffeld,, S. Hill,, N. Avila,, V. Sachdev,, L. A. Barnhart,, V. L. Anderson,, R. Clay-pool,, D. Hilligoss,, M. Garofalo,, S. Anaya-O’Brien,, D. Darnell,, R. DeCastro,, H. M. Menning,, S. M. Ricklefs,, S. F. Porcella,, K. N. Olivier,, J. Moss, and, S. M. Holland. 2008. Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome. Am. J. Respir. Crit. Care Med. 178:10661074.
13. Marras, T. K.,, and C. L. Daley. 2002. Epidemiology of human pulmonary infection with nontuberculous mycobacteria. Clin. Chest Med. 23:553567.
14. McGarvey J.,, and L. E. Bermudez. 2002. Pathogenesis of nontuberculous mycobacteria infections. Clin. Infect. Dis. 23:569583.
15. Romanus, V.,, H. O. Hollander,, P. Wahlen,, A. M. Olinder-Nielson,, P. H. W. Magnusson, and, I. Juhlin. 1995. Atypical mycobacteria in extrapulmonary disease among children. Incidence in Sweden from 1969 to 1980, related to changing BCG-vaccination coverage. Tuber. Lung Dis. 76:300310.
16. Runyon, E. H. 1959. Anonymous mycobacteria in pulmonary disease. Med. Clin. N. Am. 43:273290.
17. Sexton, P.,, and A. C. Harrison. 2008. Susceptibility to nontuberculous mycobacterial lung disease. Eur. Respir. J. 31:13221333.
18. Winthrop, K. L.,, E. Chang,, S. Yamashita,, M. F. Iadomarco, and, P. A. LoBue. 2009. Nontuberculous mycobacteria infections and anti-tumor necrosis factor-alpha therapy. Emerg. Infect. Dis. 15:15561560.

Tables

Generic image for table
Table 1.

Features of the common species

Citation: Yeager H. 2011. Nontuberculous Mycobacteria—Introduction, p 525-530. In Schlossberg D (ed), Tuberculosis and Nontuberculous Mycobacterial Infections, Sixth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817138.ch35
Generic image for table
Table 2.

Clinical and microbiologic criteria for diagnosing nontuberculous mycobacterial lung disease

Citation: Yeager H. 2011. Nontuberculous Mycobacteria—Introduction, p 525-530. In Schlossberg D (ed), Tuberculosis and Nontuberculous Mycobacterial Infections, Sixth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817138.ch35

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error